Adenosine, its analogues and conjugates;Adenozyna, jej analogi i koniugaty

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 67, Issue , 2013, Pages 1189-1203

  Samsel, Monika ^a   Dzierzbicka, Krystyna ^a   Trzonkowski, Piotr ^b  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adenosine; Adenosine analogues; Adenosine conjugates; Biological activity; Purine nucleosides

Indexed keywords

ADENOSINE; ANTIARRHYTHMIC AGENT; DRUG DERIVATIVE;

ARTICLE; HALF LIFE TIME; HUMAN; NEPHRITIS; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SUPRAVENTRICULAR TACHYCARDIA; SYNTHESIS; UVEITIS;

ADENOSINE; ANTI-ARRHYTHMIA AGENTS; ARTHRITIS, RHEUMATOID; HALF-LIFE; HUMANS; NEPHRITIS; SHOCK, SEPTIC; TACHYCARDIA, SUPRAVENTRICULAR; UVEITIS;

EID: 84892607300     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1078588     Document Type: Article

References (55)

1. Aye Y., Stubbe J.: Clofarabine 5'-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit. Proc. Natl. Acad. Sci. USA, 2011;108:9815-9820
2. Bednarska K., Olejniczak A. B., Piskala A., Klink M., Sulowska Z., Lesnikowski Z. J.: Effect of adenosine modified with a boron cluster pharmacophore on reactive oxygen species production by human neutrophils. Bioorg. Med. Chem., 2012;20:6621-6629
3. Ben Addi A., Lefort A., Hua X., Libert F., Communi D., Ledent C., Macours P., Tilley S. L., Boeynaems J. M., Robaye B.: Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A (2B) receptor. Eur. J. Immunol., 2008;38:1610-1620
4. Borsellino G., Kleinewietfeld M., Di Mitri D., Sternjak A., Diamantini A., Giometto R., Höpner S., Centonze D., Bernardi G., Dell'Acqua M. L., Rossini P. M., Battistini L., Rötzschke O., Falk K.: Expression of ectonucleotidase CD39 by Foxp3 (+) Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood, 2007;110:1225-1232
5. Cappellacci L., Franchetti P., Vita P., Petrelli R., Lavecchia A., Costa B., Spinetti F., Martini C., Klotz K. N., Grifantini M.: 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A (1) adenosine receptor agonists: Affinity, efficacy, and selectivity for A (1) receptor from different species. Bioorg. Med. Chem., 2008;16:336-353
6. 6- disubstituted adenine ribo- and 3'-C-methyl-ribonucleosides as antitumor agents. Eur. J. Med. Chem., 2011;46:1499-1504
7. Chavain N., Herdewijn P.: 2'-Deoxy-2'-α-C-(hydroxymethyl) adenosine as potential anti-HCV agent. Eur. J. Org. Chem., 2011;2011:1140-1147
8. Chen L., Petrelli R., Olesiak M., Wilson D. J., Labello N. P., Pankiewicz K. W.: Bis (sulfonamide) isosters of mycophenolic adenine dinucleotide analogues: inhibition of inosine monophosphate dehydrogenase. Bioorg. Med. Chem., 2008;16:7462-7469
9. Czene S, Harms-Ringdahl M.: Detection of single-strand breaks and formamidopyrimidine-dna glycosylase-sensitive sites in dna of cultured human fibroblasts. Mutat. Res., 1995;336:235-242
10. Deaglio S., Dwyer K. M., Gao W., Fredman D., Usheva A., Reat A., Chen J. F., Enjyoji K., Linden J., Oukka M., Kuchroo V. K., Strom T. B., Robson S. C.: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med., 2007;204:1257-1265
11. Eliahu S., Lecka J., Reiser G., Haas M., Bigonnesse F., Levesque S. A., Pelletier J., Sevigny J., Fischer B.: Diadenosine 5', 5"-(boranated) polyphosphonate analogues as selective nucleotide pyrophosphatase/ phosphodiesterase inhibitors. J. Med. Chem., 2010;53:8485-8497
12. Gadthula S., Rawal R. K., Sharon A., Wu D., Korba B., Chu C. K.: Synthesis and antiviral activity of cyclopropyl-spirocarbocyclic adenosine, (4R, 5S, 6R, 7R)-4-(6-amino-9H-purin-9-yl)-7-(hydroxymethyl) spiro [2. 4] heptane-5, 6-diol against hepatitis C virus. Bioorg. Med. Chem. Lett., 2011;21:3982-3985
13. Godzik P., Komorowski M., Cielecka-Kuszyk J., Madalinski K.: Inhibitors of hepatitis C virus-current standards and status of investigations. Przegl. Epidemiol., 2010;64:473-478
14. Halliwell B., Dizdaroglu M.: The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic. Res. Commun., 1992;16:75-87
15. Hickey P., Stacy M.: Adenosine A2A antagonists in Parkinson's disease: what's next? Curr. Neurol. Neurosci. Rep., 2012;12:376-385
16. Hofer M., Pospisil M., Weiterowa L., Hoferova Z.: The role of adenosine receptor agonists in regulation of hematopoiesis. Molecules, 2011;16:675-685
17. Hori M., Suzuki T., Minakawa N., Matsuda A., Harashima H., Kamiya H.: Mutagenicity of secondary oxidation products of 8-oxo-7, 8-dihydro-2'- deoxyguanosine 5'-triphosphate (8-hydroxy-2'-deoxyguanosine 5'-triphosphate). Mutat. Res. - Fund. Mol. M, 2011;714:11-16
18. Hwu J. R., Lin S. Y., Tsay S. C., De Clercq E., Leyssen P., Neyts J.: Coumarin-purine ribofuranoside conjugates as new agents against hepatitis C virus. J. Med. Chem., 2011;54:2114-2126
19. Ichikawa E., Kato K.: Sugar-modified nucleosides in past 10 years, a review. Curr. Med. Chem., 2001;8:385-423
20. Jacobson K., Gao Z. G.: Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov, 2006;5:247-264
21. Jacobson K. Joshi B., Wang B., Klutz A., Kim Y., Ivanov A.: Modified nucleosides as selective modulators of adenosine receptors for therapeutic use. W: Modified Nucleosides: in Biochemistry, Biotechnology and Medicine. Red. Herdewijn P. D., Wiley-VCH, Weinheim, 2008, 433-449
22. Jacobson K. A., Xie R. Y., Young L., Chang L., Liang B. T.: A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists. J. Biol. Chem., 2000;275:30272-30279
23. Johnston J. B.: Mechanism of action of pentostatin and cladribine in hairy cell leukemia. Leuk. Lymphoma, 2011;52, Suppl. 2:43-45
24. Lam P. M., Mistry V., Marczylo T. H., Konje J. C., Evans M. D., Cooke M. S.: Rapid measurement of 8-oxo-7, 8-dihydro-2 '-deoxyguanosine in human biological matrices using ultra-high-performance liquid chromatography-tandem mass spectrometry. Free Radic. Biol. Med., 2012;52:2057-2063
25. Lech-Maranda E., Korycka A., Robak T.: Pharmacological and clinical studies on purine nucleoside analogs - new anticancer agents. Mini Rev. Med. Chem., 2006;6:575-581
26. Lee W. H., Choi W. J. Jacobson K. A., Jeong L. S.: Synthesis and binding affinity of homologated adenosine analogues as A3 adenosine receptor ligands. Bull. Korean Chem. Soc, 2011;32:1620-1624
27. Lin W., Buolamwini K.: Design, synthesis, and evaluation of 2-diethanolamino-4, 8-diheptamethyleneimino-2-(N-aminoethyl-N-ethanol amino)-6-(N, N-diethanolamino) pyrimido [5, 4-d]pyrimidine-fluorescein (8MDP-fluor), as a novel equilibrative nucleoside transporter probe. Bioconjug. Chem., 2011;22:1221-1227
28. Lynch M. E., Clark A. J., Sawynok J.: Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design. Pain, 2003;103:111-117
29. Mathew S. C., Ghosh N., By Y., Berthault A., Virolleaud M. A., Carrega L., Chouraqui G., Commeiras L., Condo J., Attolini M., Gaudel-Siri A., Ruf J., Parrain J. L., Rodriguez J., Guieu R.: Design, synthesis and biological evaluation of a bivalent mu opiate and adenosine A1 receptor antagonist. Bioorg. Med. Chem. Lett., 2009;19:6736-6739
30. Moreau C, Ashamu G. A., Bailey V. C., Galione A., Guse A. H., Potter B. V.: Synthesis of cyclic adenosine 5'-diphosphate ribose analogues: a C2' endo/syn "southern" ribose confirmation underlies activity at the sea urchin cADPR receptor. Org. Biomol. Chem., 2011;9:278-290
31. Nahum V., Fischer B.: Boranophosphate salts as an excellent mimic of phosphate salts: preparation, characterization, and properties. Eur. J. Inorg. Chem., 2004;2004:4124-4131
32. 6-Alkyladenosines: synthesis and evaluation of in vitro anticancer activity. Bioorg. Med. Chem., 2010;18:8396-8402
33. Pankiewicz K. W., Lesiak-Watanabe K. B., Watanabe K. A., Patterson S. E., Jayaram H. N., Yalowitz J. A., Miller M. D., Seidman M., Majumdar A., Prehna G., Goldstein B. M.: Novel mycophenolic adenine bis (phosphonate) analogues as potential differentiation agents against human leukemia. J. Med. Chem., 2002;45:703-712
34. Pei X., Choi W. J., Kim Y. M., Zhao L. X., Jeong L. S.: Synthesis of 3 '-C-hydroxymethyl-substituted pyrimidine and purine nucleosides as potential anti-hepatitis C virus (HCV) agents. Arch. Pharmacol. Res., 2008;31:843-849
35. Podgórska M., Kocbuch K., Pawełczyk T.: Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta Biochim. Pol., 2005;52:749-758
36. Popsavin M., Spaić S., Svirčev M., Kojić V., Bogdanović G., Popsavin V.: Synthesis and in vitro antitumour screening of 2-(β-d-xylofuranosyl) thiazole-4-carboxamide and two novel tiazofurin analogues with substituted tetrahydrofurodioxol moiety as a sugar mimic. Bioorg. Med. Chem. Lett., 2012;22:6700-6704
37. Poulsen S. A., Quinn R. J.: Adenosine receptors: new opportunities for future drugs. Bioorg. Med. Chem., 1998;6:619-641
38. Power Coombs M. R., Belderbos M. E., Gallington L. C., Bont L., Levy O.: Adenosine modulates Toll-like receptor function: basic mechanisms and translational opportunities. Expert Rev. Anti Infect. Ther., 2011;9:261-269
39. Raagel H., Lust M., Uri A., Pooga M.: Adenosine-oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton. FEBS Lett., 2008;275:3608-3624
40. Ravanat J. L., Turesky R. J., Gremaud E., Trudel L. J., Stadler R. H.: Determination of 8-oxoguanine in dna by gas-chromatography mass-spectrometry and hplc-electrochemical detection - overestimation of the background level of the oxidized base by the gas-chromatography mass-spectrometry assay. Chem. Res. Toxicol., 1995;8:1039-1045
41. Robak T., Korycka A., Kasznicki M., Wrzesien-Kus A., Smolewski P.: Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications. Curr. Cancer Drug Tar., 2005;5:421-444
42. Robak T., Korycka A., Lech-Maranda E., Robak P.: Current status o folder and new purine nucleoside analogues in the treatment of lymphoproliferative diseases. Molecules, 2009;14:1183-1226
43. Samsel M., Dzierzbicka K.: Therapeutic potential of adenosine analogues and conjugates. Pharmacol. Rep., 2011;63:601-617
44. Shibutani S., Takeshita M., Grollaman A. P.: Insertion of specific bases during DNA-synthesis past the oxidation-damaged base 8-oxoDG. Nature, 1991;349:431-434
45. Silverman M. H., Strand V., Markovits D., Nahir M., Reitblat T., Molad Y., Rosner I., Rozenbaum M., Mader R., Adawi M., Caspi D., Tishler M., Langevitz P., Rubinow A., Friedman J. i wsp.: Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. J. Rheumatol., 2008;35:41-48
46. Stuyver L., McBrayer T., Tharnish P., Clark J., Hollecker L., Lostia S., Nachman T., Grier J., Bennett M., Xie M., Schinazi R. F., Morrey J. D., Julander J. L., Furman P. A., Otto M. J.: Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Antivir. Chem. Chemother., 2006;17:79-87
47. Su Y. Y., Jackson E. K., Gorelik E.: Receptor desensitization and blockade of the suppressive effects of prostaglandin E (2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes. Cancer Immunol. Immunother., 2011;60:111-122
48. Taniguchi Y., Kawaguchi R., Sasaki S.: Adenosine-1, 3-diazaphenoxazine derivative for selective base pair formation with 8-oxo-2'-deoxyguanosine in DNA. J. Am. Chem. Soc., 2011;133:7272-7275
49. Wei C. J., Li W., Chen J. F.: Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies. Biochim. Biophys. Acta, 2011;1808:1358-1379
50. Xie G. H., Rah S. Y., Kim S. J., Nam T. S., Ha K. C., Chae S. W., Im M. J., Kim U. H.: ADP-ribosyl cyclase couples to cyclic AMP signaling in the cardiomyocytes. Biochem. Biophys. Res. Commun., 2005;330:1290-1298
51. Xue L., Greenberg M. M.: Facile quantification of lesions derived from 2'-deoxyguanosine in DNA. J. Am. Chem. Soc., 2007;129:7010-7011
52. Yoo B. N., Kim H. O., Moon H. R., Seol S. K., Jang S. K., Lee K. M., Jeong L. S.: Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents. Bioorg. Med. Chem. Lett., 2006;16:4190-4194
53. Yu Q., Carlsen P.: Synthesis of a novel benzoyl adenosine analog containing a 1, 4-dioxane sugar analog and the synthesis of a corresponding uracil adenine dinucleotide. Molecules, 2011;16:3985-3998
54. Zhou X. J., Pietropaolo K., Chen J., Khan S., Sullivan-Bolyai J., Mayers D.: Safety and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus, in healthy subjects. Antimicrob. Agents Chemother., 2011;55:76-81
55. Zhu R., Frazier C. R., Linden J., Macdonald T. L.: N-6-Ethyl-2-alkynyl NECAs, selective human A (3) adenosine receptor agonists. Bioorg. Med. Chem. Lett., 2006;16:2416-2418